https://scholars.lib.ntu.edu.tw/handle/123456789/639670
標題: | Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer | 作者: | YEN-TING LIN CHAO-CHI HO Hsu, Wei-Hsun WEI-YU LIAO CHING-YAO YANG CHONG-JEN YU TZU-HSIU TSAI CHIH-HSIN YANG SHANG-GIN WU CHIA-LIN HSU Hsieh, Min-Shu YEN-LIN HUANG Wu, Chia-Ling JIN-YUAN SHIH |
關鍵字: | EGFR mutation; EGFR-TKI resistance; NSCLC; next-generation sequencing | 公開日期: | 2024 | 卷: | 13 | 期: | 1 | 來源出版物: | Cancer medicine | 摘要: | According to current International Association for the Study of Lung Cancer guideline, physicians may first use plasma cell-free DNA (cfDNA) methods to identify epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-resistant mechanisms (liquid rebiopsy) for lung cancer. Tissue rebiopsy is recommended if the plasma result is negative. However, this approach has not been evaluated prospectively using next-generation sequencing (NGS). |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/639670 | ISSN: | 2045-7634 | DOI: | 10.1002/cam4.6870 |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。